IGC Pharma Inc (IGC)
0.4354
+0.01
(+1.26%)
USD |
NYAM |
Apr 26, 09:38
IGC Pharma Debt to Equity Ratio: 0.0152 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0152 |
| September 30, 2023 | 0.0099 |
| June 30, 2023 | 0.0106 |
| March 31, 2023 | 0.0095 |
| December 31, 2022 | 0.0077 |
| September 30, 2022 | 0.007 |
| June 30, 2022 | 0.0066 |
| March 31, 2022 | 0.006 |
| December 31, 2021 | 0.005 |
| September 30, 2021 | 0.0048 |
| June 30, 2021 | 0.0047 |
| March 31, 2021 | 0.0177 |
| December 31, 2020 | 0.027 |
| September 30, 2020 | 0.0246 |
| June 30, 2020 | 0.0253 |
| March 31, 2020 | 0.0019 |
| December 31, 2019 | 0.0017 |
| September 30, 2019 | 0.0016 |
| June 30, 2019 | 0.0015 |
| March 31, 2019 | 0.0015 |
| December 31, 2018 | 0.0018 |
| September 30, 2018 | 0.1467 |
| June 30, 2018 | 0.2674 |
| March 31, 2018 | 0.2761 |
| December 31, 2017 | 0.339 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.4094 |
| June 30, 2017 | 0.3874 |
| March 31, 2017 | 0.3593 |
| December 31, 2016 | 0.3801 |
| September 30, 2016 | 0.1958 |
| June 30, 2016 | 0.1941 |
| March 31, 2016 | 0.2092 |
| December 31, 2015 | 0.2282 |
| September 30, 2015 | 0.229 |
| June 30, 2015 | 0.2742 |
| March 31, 2015 | 0.2443 |
| December 31, 2014 | 0.2143 |
| September 30, 2014 | 0.2218 |
| June 30, 2014 | 0.1987 |
| March 31, 2014 | 0.1633 |
| December 31, 2013 | 0.153 |
| September 30, 2013 | 0.154 |
| June 30, 2013 | 0.1614 |
| March 31, 2013 | 0.1556 |
| December 31, 2012 | 0.1524 |
| September 30, 2012 | 0.1544 |
| June 30, 2012 | 0.1538 |
| March 31, 2012 | 0.1714 |
| December 31, 2011 | 0.3266 |
| September 30, 2011 | 0.7576 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0015
Minimum
Jun 2019
0.027
Maximum
Dec 2020
0.0099
Average
0.007
Median
Sep 2022
Debt to Equity Ratio Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Protalix BioTherapeutics Inc | 0.6033 |
| Palatin Technologies Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 11.26M |
| Total Liabilities (Quarterly) | 2.206M |
| Shareholders Equity (Quarterly) | 9.053M |
| Current Ratio | 1.851 |
| Net Debt Paydown Yield | 0.00% |